Guifen Shen

444 total citations
15 papers, 280 citations indexed

About

Guifen Shen is a scholar working on Rheumatology, Immunology and Infectious Diseases. According to data from OpenAlex, Guifen Shen has authored 15 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Guifen Shen's work include Cancer, Hypoxia, and Metabolism (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Guifen Shen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Guifen Shen collaborates with scholars based in China, United States and Germany. Guifen Shen's co-authors include Lingli Dong, Jixin Zhong, Cong Ye, Shaozhe Cai, Yikai Yu, Yuxue Chen, Wei Tu, Yú Chen, Hanxiong Guan and Yangyang Hu and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and European Journal of Immunology.

In The Last Decade

Guifen Shen

14 papers receiving 273 citations

Peers

Guifen Shen
Caroline H. Siegel United States
Guifen Shen
Citations per year, relative to Guifen Shen Guifen Shen (= 1×) peers Caroline H. Siegel

Countries citing papers authored by Guifen Shen

Since Specialization
Citations

This map shows the geographic impact of Guifen Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifen Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifen Shen more than expected).

Fields of papers citing papers by Guifen Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guifen Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifen Shen. The network helps show where Guifen Shen may publish in the future.

Co-authorship network of co-authors of Guifen Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Guifen Shen. A scholar is included among the top collaborators of Guifen Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guifen Shen. Guifen Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xing, Rui, Fenfen Xiang, Lingli Dong, & Guifen Shen. (2023). Spontaneous intramuscular hemorrhage in cancer-associated dermatomyositis: a case and literature review. BMC Musculoskeletal Disorders. 24(1). 542–542. 2 indexed citations
2.
Peng, Liyuan, Jingbo Liu, Houjuan Zuo, & Guifen Shen. (2023). Unusual presentation of systemic lupus erythematosus as hemophagocytic lymphohistiocytosis in a female patient: A case report. World Journal of Clinical Cases. 11(4). 909–917.
3.
4.
Yan, Hui, et al.. (2022). Sphingosine-1-Phosphate Protects Against the Development of Cardiac Remodeling via Sphingosine Kinase 2 and the S1PR2/ERK Pathway. Current Medical Science. 42(4). 702–710. 7 indexed citations
5.
Shen, Guifen, et al.. (2021). Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy. International Journal of Rheumatic Diseases. 24(6). 815–827. 19 indexed citations
6.
Zhong, Jixin, Guifen Shen, Huiqin Yang, et al.. (2020). COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. The Lancet Rheumatology. 2(9). e557–e564. 79 indexed citations
7.
Ye, Cong, Shaozhe Cai, Guifen Shen, et al.. (2020). Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Annals of the Rheumatic Diseases. 79(8). 1007–1013. 82 indexed citations
8.
Shen, Guifen, Stefan Krienke, Petra Schiller, et al.. (2017). Microvesicles released by apoptotic human neutrophils suppress proliferation and IL‐2/IL‐2 receptor expression of resting T helper cells. European Journal of Immunology. 47(5). 900–910. 30 indexed citations
9.
Ye, Cong, Guifen Shen, Shouxin Li, et al.. (2016). Human brucellosis mimicking axial spondyloarthritis: a challenge for rheumatologists when applying the 2009 ASAS criteria. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(3). 368–371. 3 indexed citations
10.
Chen, Jing, Xia Zhao, Sheng Zhou, et al.. (2016). A Point-Scoring System for the Clinical Diagnosis of Sjögren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland. PLoS ONE. 11(5). e0155666–e0155666. 8 indexed citations
11.
Shen, Guifen, et al.. (2016). Subcutaneous Panniculitis-like T Cell Lymphoma Mimicking Early-Onset Nodular Panniculitis. American Journal of Case Reports. 17. 429–433. 7 indexed citations
12.
Chen, Yu, Wei Sun, Yuying Su, et al.. (2015). Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.. PubMed. 33(2). 187–94. 8 indexed citations
13.
Yu, Yikai, Fei Yu, Cong Ye, et al.. (2015). Combination Therapies of Diacerein and Febuxostat Inhibit IL-1β Responses and Improve Clinical Symptoms in Patients With Refractory Gout. American Journal of Therapeutics. 24(3). e290–e297. 7 indexed citations
14.
Shen, Guifen, et al.. (2009). Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells.. PubMed. 28(1). 14–9. 4 indexed citations
15.
Shen, Guifen, et al.. (2008). [Promotive effects of epoxyeicosatrienoic acids (EETs) on proliferation of tumor cells].. PubMed. 27(11). 1130–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026